4.8 Article

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma

Michael P. Smith et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Multidisciplinary Sciences

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition

Rizwan Haq et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Medicine, General & Internal

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Biochemical Research Methods

A public genome-scale lentiviral expression library of human ORFs

Xiaoping Yang et al.

NATURE METHODS (2011)

Article Medicine, General & Internal

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

An Oncogenic Role for ETV1 in Melanoma

Judit Jane-Valbuena et al.

CANCER RESEARCH (2010)

Article Multidisciplinary Sciences

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Cory M. Johannessen et al.

NATURE (2010)

Article Oncology

Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage

Satoru Yokoyama et al.

PIGMENT CELL & MELANOMA RESEARCH (2008)

Article Multidisciplinary Sciences

BRAF mutation predicts sensitivity to MEK inhibition

DB Solit et al.

NATURE (2006)

Article Biochemistry & Molecular Biology

Genetics of melanoma predisposition

NK Hayward

ONCOGENE (2003)

Review Cell Biology

Seven-transmembrane receptors

KL Pierce et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)